OverviewChartNewsTraderScreen

E.ON SE/  US2687801033  /

Nasdaq Other OTC
13/06/2024  16:45:14 Chg. -0.1950 Volume Bid- Ask- High Low
13.1850USD -1.46% 1,550
Turnover: 17,320.8900		 -Bid Size: - -Ask Size: - 13.3500 13.1800
GlobeNewswire 17:00 Thrilling Novel Takes Readers On Perilous Mission Back From Mars
GlobeNewswire 14:00 Apotea Expands Agreement with RightHand Robotics to Deploy RightPick™ Item-Handling System in New Lo...
GlobeNewswire 12/06 Evaluating The Balance of Power In The Afterword Of Trump’s Presidency: The Pros and Cons With A Hin...
Newsfile Corp 12/06 Emergia Inc. annonce la signature d'une lettre d'intention pour une fusion avec Kraken Holding
TeleTrader 12/06 Europe closes sharply higher as Fed's decision nears
GlobeNewswire 06/06 ViaDerma Provides Highlights of Quarterly Financial Report
GlobeNewswire 06/06 ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medic...
GlobeNewswire 01/06 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 29/05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 21/05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 07/05 ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 25/04 Gatos Silver Reports South-East Deeps Drilling Results at Cerro Los Gatos and Announces Executive Ap...
GlobeNewswire 23/04 ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Invest...
GlobeNewswire 22/04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 07/04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 04/04 AINewsWire Named Official Newswire of R.AI.SE Summit
GlobeNewswire 20/03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 11/03 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire 11/03 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 07/03 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...
GlobeNewswire 07/03 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 06/03 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...